# Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats.

> PubMed lists PMID 20604834 in The Journal of pharmacy and pharmacology as Journal Article, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-20604834-lanreotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-20604834-lanreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-20604834-lanreotide-v1.json
- Content SHA-256: `98f3f7989c5d2988ac8f6ca54d4bcbf8199f9c1742e3132ca7ac44b7cc323767`

## Claims and source pins

### Headline

Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats. ([`pubmed-observation-pmid-20604834-2016-11-25-695da1512200`](#source-pubmed-observation-pmid-20604834-2016-11-25-695da1512200))

### Summary

PubMed lists PMID 20604834 in The Journal of pharmacy and pharmacology as Journal Article, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20604834-2016-11-25-695da1512200`](#source-pubmed-observation-pmid-20604834-2016-11-25-695da1512200))

### Paragraph 1

PubMed lists PMID 20604834 in The Journal of pharmacy and pharmacology as Journal Article, with publication-date metadata of 2010-04 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20604834-2016-11-25-695da1512200`](#source-pubmed-observation-pmid-20604834-2016-11-25-695da1512200))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-20604834-2016-11-25-695da1512200`](#source-pubmed-observation-pmid-20604834-2016-11-25-695da1512200))

## Sources

<a id="source-pubmed-observation-pmid-20604834-2016-11-25-695da1512200"></a>
- **Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats. · retained source version 1:2016-11-25:current:695da151220066cdbfe3d0b90f22a4c1ea7783871cba56aad6e8c6dcb80f95b1** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/20604834/) (`pubmed-observation-pmid-20604834-2016-11-25-695da1512200`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-20604834-lanreotide-v1.json SHA-256: 98f3f7989c5d2988ac8f6ca54d4bcbf8199f9c1742e3132ca7ac44b7cc323767.